Microgravity Enhances Protein Crystallization

Two Biochemistry researchers recently sent protein crystallization samples into space aboard the Space X Dragon capsule. The samples will spend several months at the International Space Station (ISS) U.S. National Laboratory before returning to Earth for analysis. More

PRF Fall 2013 Awardees

The RPC has announced the recipients of the President's Research Fund awards for the Fall 2013 cycle. More

Pharm/Phys Faculty Member Receives Award

Daniela Salvemini, Ph.D., Professor of Pharmacological & Physiological Science, will be awarded an Outstanding Scientist Award by the Academy of Science of St. Louis in April. More

Researchers Study Therapy To Relieve Sickle Cell Pain

William Ferguson, M.D., will head a study to determine whether ReoPro can help children and young adults experiencing severe pain from sickle cell disease events. More

StealthStation Improves Neurosurgery

Richard Bucholz, M.D., FACS, was named a Fellow of the National Academy of Inventors for his invention of the "StealthStation" surgical tracking system.

Sinus Study Unlocks Cause of Chronic Rhinosinusitus

Rajeev Aurora, Ph.D., and Thomas Sanford, M.D., recently published an article in JAMA-Otolaryngology Head & Neck Surgery on the causes of chronic rhinosinusitis. More

Discovery of Pain Molecule Will Help Fight Chemo Pain

Daniela Salvemini, Ph.D, was awarded grants from the Leukemia & Lymphoma Society and the National Institutes of Health to continue her studies on pain associated with chemotherapy treatment. More

NIAID Contract Continues to Fourth Year

Mark Buller, Ph.D., and William Wold, Ph.D., have received a fourth year of funding for their contract entitled “Animal Models of Infectious Diseases.” More

Sly Syndrome Clinical Trial Begins Soon

Ultragenyx will begin testing a recombinant enzyme replacement therapy for Sly syndrome,
a lysosomal storage disease discovered by Dr. William Sly in 1973. More

Inhibition of "Fork Reversal" Improves Cancer Treatment

Alessandro Vindigni, Ph.D, Associate Professor of Biochemistry, recently published an article in Nature Structural & Molecular Biology describing his lab’s recent research on how cancer cells respond to topoisomerase I (TOP1) inhibitors, a common class of anti-cancer drugs used in chemotherapy. More

Pediatric Researchers Featured in Grand Rounds

Five researchers in the Department of Pediatrics, Stephen Barenkamp, M.D., Robert Fleming, M.D., Noah H. Hillman, M.D., Adriana Montaño, Ph.D., and Joyce Marie Koenig, M.D., are featured in the Spring 2013 issue of Grand Rounds magazine. More

Cancer Drugs Combat Bioterrorism

Mark Buller, Ph.D., of the Department of Molecular Microbiology and Immunology, received a grant from the U.S. Defense Threat Reduction Agency (DTRA) to study the antiviral properties of two cancer drugs and their ability to treat monkeypox infections in the event of a bioterrorism attack. More

About

The RPC is the advisory body to the Dean about policies, activities, and long-term objectives pertaining to research in the School of Medicine.

Members are appointed by the Dean to a 3-year term, with the recommendations of the Committee on Faculty Affairs.

Activities of the RPC include: